MIM
BIVV

MetLife Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

MetLife Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-68,434
Closed -$3.69M – 2247
2017
Q4 		$3.69M Buy
+68,434
New +$3.74M 0.04% 512

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

MetLife Investment Management's BIVV Position: Q1 2018 in Review

MetLife Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 68,434 shares — an estimated $3.69M sold.

MetLife Investment Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $3.69M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • MetLife Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • MetLife Investment Management sold 68,434 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3.69M.
  • MetLife Investment Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • MetLife Investment Management's Bioverativ Inc. Common Stock position peaked at $3.69M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on MetLife Investment Management's 13F filing for Q1 2018, filed 15 May 2018.